the incidence of cardiac death and nonfatal myocardial infarction , considered together , was 8.6 per cent in the groups given aspirin and 17.0 per cent in the other groups , representing a risk reduction with aspirin of 51 per cent ( p = 0.008 ) .
C0027051
myocardial infarction
C0004057
aspirin